BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15461812)

  • 1. Apolipoprotein M.
    Luo G; Zhang X; Nilsson-Ehle P; Xu N
    Lipids Health Dis; 2004 Oct; 3():21. PubMed ID: 15461812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
    Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
    Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of apolipoprotein M during mouse and human embryogenesis.
    Zhang XY; Jiao GQ; Hurtig M; Dong X; Zheng L; Luo GH; Nilsson-Ehle P; Ye Q; Xu N
    Acta Histochem; 2004; 106(2):123-8. PubMed ID: 15147633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein M: progress in understanding its regulation and metabolic functions.
    Christoffersen C; Dahlbäck B; Nielsen LB
    Scand J Clin Lab Invest; 2006; 66(7):631-7. PubMed ID: 17101555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
    Xu N; Nilsson-Ehle P; Ahrén B
    J Nutr Biochem; 2004 Oct; 15(10):579-82. PubMed ID: 15542348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
    Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization.
    Zhang XY; Dong X; Zheng L; Luo GH; Liu YH; Ekström U; Nilsson-Ehle P; Ye Q; Xu N
    Acta Histochem; 2003; 105(1):67-72. PubMed ID: 12666989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
    Faber K; Hvidberg V; Moestrup SK; Dahlbäck B; Nielsen LB
    Mol Endocrinol; 2006 Jan; 20(1):212-8. PubMed ID: 16099815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.
    Huang XS; Zhao SP; Hu M; Luo YP
    Med Hypotheses; 2007; 69(1):136-40. PubMed ID: 17218068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
    Cervin C; Axler O; Holmkvist J; Almgren P; Rantala E; Tuomi T; Groop L; Dahlbäck B; Karlsson E
    J Intern Med; 2010 Mar; 267(3):316-21. PubMed ID: 19754856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
    Yang L; Zhao S
    Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
    Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
    Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY.
    Skupien J; Kepka G; Gorczynska-Kosiorz S; Gebska A; Klupa T; Wanic K; Nowak N; Borowiec M; Sieradzki J; Malecki MT
    Rev Diabet Stud; 2007; 4(4):231-5. PubMed ID: 18338076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel human apolipoprotein (apoM).
    Xu N; Dahlbäck B
    J Biol Chem; 1999 Oct; 274(44):31286-90. PubMed ID: 10531326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
    Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
    Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
    Xu N; Nilsson-Ehle P; Ahrén B
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoM: gene regulation and effects on HDL metabolism.
    Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
    Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
    Dullaart RP; Plomgaard P; de Vries R; Dahlbäck B; Nielsen LB
    Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.